ICCR 2023 - Event Info Site

Detailed Programme

25 November 2023 (Saturday)
08:30-12:00	粵港風濕病研討會 Hong Kong Guangdong Rheumatology Meeting 主席: 葉玉津教授和余嘉龍醫生Chairpersons: Prof Yujin YE and Dr Carrel YU Diagnosis and Treatment of ILD With Anti-MDA5 Antibody Positive Dermatomyositis ⻩⽂輝教授(中國) Prof Wen-Hui HUANG (China) Immunometabolism in the Pathogenesis of Lupus Nephritis 張輝教授 (中國) Prof Hui ZHANG (China) Fusobacterium Nucleatum Aggravates Rheumatoid Arthritis Through Outer Membrane Vesicles 洪睦鏗博⼠ (中國) Dr Mukeng HONG (China) Salivary Gland Gene Therapy in Sjögren's Syndrome 莫穎倩博⼠ (中國) Dr Yingqian MO (China) ACR and EULAR Management Guidelines for Rheumatoid Arthritis: Consistency and Controversy 蘇晧教授 (香港) Prof Ho SO (Hong Kong)
09:00-12:00	MRI Workshop for Axial Spondyloarthritis 2023 (sponsored by Novartis) Chairperson: Dr Shirley CHAN Spinal MRI Lesions in Axial SpA Dr Ho Yin CHUNG (Hong Kong) Interpretation of MRI SI Joint Dr Victor LEE* (Hong Kong)* Hand On Workshop Shantung Room, Level 8
09:30-12:00	Nursing Session (sponsored by Janssen) Chairperson: Ms Yin Shuen CHEUNG and Ms Manly TANG PSA and Mental Health/ Cosmetic Treatment and Flare Up -- Dr Michelle NG (Hong Kong) PSA, Pain Management, Chronic Pain Management, Daily Nurse Practice Ms Linda BRADBURY (Australia) Shanghai Room, Level 8
10:30-11:00	Break
12:00-13:00	Lunch Symposium (sponsored by Janssen) Chairperson: Dr Priscilla WONG Optimization of Disease Management in CTD-PAH from Early Screening to Reassessment Dr Wendy STEVENS* (Australia)*
13:00-13:30	Opening Ceremony
13:30-14:15	Opening Lecture (sponsored by Pfizer) Chairperson: Dr Chi Hung TO Novel Treatment Algorithms in Axial Spondyloarthritis – What is the Current Status? Dr Xenofon BARALIAKOS (Germany)
14:15-14:45	Symposium 1 Chairperson:Dr Chi Chiu MOK Lupus Nephritis Biomarkers: Are We There Yet? Prof Chandra MOHAN (United States)
14:45-15:15	Break, Exhibition & e-Poster Viewing
15:15-16:15	Symposium 2 (sponsored by AbbVie) Chairperson: Dr Ho Yin CHUNG Tailoring PsA Therapy to Fit the Patient with JAK and IL23 Inhibition Prof Lars Erik KRISTENSEN* (Denmark)*
16:15-16:45	Symposium 3 Chairperson:Dr Grace HO Improving the Outcome of Systemic Sclerosis Prof Masataka KUWANA* (Japan)*

26 November 2023 (Sunday)
08:30-09:30	Free Paper Presentation Chairpersons: Dr Natalia CIANG and Dr Billy LAI Adjudicators: Dr Carmen HO, Dr Kei IKEDA and Dr KL LEE Derivation and Internal Validation of a Multi-Biomarker-Based Disease Activity Prediction Score for Psoriatic Arthritis Patients Ms Yingzhao JIN (Hong Kong) Deep Learning Differentiation of Inflammatory Lesions in Sacroiliac Joint MRI Based on Spondyloarthritis Research Consortium of Canada (SPARCC) System Dr Ho Yin CHUNG (Hong Kong) Comparison of the ASAS Health Index Between Radiographic Axial Spondyloarthritis and Non-Radiographic Spondyloarthritis in Singapore Dr Yu Heng KWAN (Singapore) Lupus Low Disease Activity State: An Underutilised Clinical Target that is Attainable and Protective against Lupus Nephritis Relapse Mr Chak Kwan CHEUNG (Hong Kong) Risk of Liver Injury in Psoriasis and Rheumatoid Arthritis is Associated with Metabolic Risk Factors Rather than Methotrexate and Leflunomide Dr Ho Yin CHUNG (Hong Kong)
09:30-10:30	Symposium 4 (sponsored by Boehringer Ingelheim) Chairpersons: Dr Steve PANG and Dr Lydia TAM What do we know about ILD in RA? –Approach on Identification and Management Prof Vanessa SMITH(Belgium) RA-ILD Screening and Evaluation in High-Risk Patients Study in Hong Kong Dr Shirley CHAN (Hong Kong)
10:30-11:00	Break, Exhibition & e-Poster Viewing
11:00-11:30	Symposium 5 Chairperson: Dr Stella WONG Ultrasonography as Imaging Outcome Tools in Autoimmune Myositis Dr Kei IKEDA (Japan)
11:30-12:00	Symposium 6 (sponsored by AstraZeneca) Chairperson: Dr Carmen HO Biological Therapies for Systemic Lupus Erythematosus: Something Old, Something New Dr Chi Chiu MOK (Hong Kong)
12:00-12:30	Symposium 7 Chairperson: Dr Kitty KWOK How Much We Know about Pre-Clinical Rheumatoid Arthritis? Prof João Eurico FONSECA (Portugal)
12:30-13:30	Lunch Symposium (sponsored by Eli Lilly) Chairperson: Dr Cheuk Wan YIM Finding the Right Treatment for the Right Patient - What Similarities and Key Differences among RA, PsA and axSpA Determine Treatment Decisions Prof Mikkel ØSTERGAARD(Denmark)
13:30-14:00	Symposium 8 (sponsored by Janssen) Chairperson: Prof Lai Shan TAM Role of IL-23 Inhibitors in PsA Management - Can It Be Considered Upfront? Prof Peter NASH(Australia)
14:00-14:30	Symposium 9 Chairperson: Dr Ho SO Recent Advances in Treatment of Myositis Prof Rohit AGGARWAL (United States)
14:30-15:00	Break, Exhibition & e-Poster Viewing
15:00-15:30	Symposium 10 (sponsored by GlaxoSmithKline) Chairperson: Dr Clara LAW Spotting EGPA from Asthma Populations and How Co-Care Works Between Rheumatology and Respiratory Physicians: A Case Sharing Dr Ping-Hung KUO (Chinese Taipei)
15:30-16:00	Symposium 11 Chairperson: Dr Tommy CHEUNG Treating Infection with Immunosuppression - an Emerging Spectrum of Autoimmunity Dr Philip LI (Hong Kong)
16:00-16:15	Closing Ceremony

The programme is subject to change without prior notice.